- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 2 x R1H: tariquidar(Non-covalent)
- 11 x CLR: CHOLESTEROL(Non-covalent)
CLR.3: 7 residues within 4Å:- Chain A: T.112, A.115, Y.116, S.119, F.944, F.951
- Ligands: CLR.4
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:A.115, A:Y.116, A:F.944, A:F.951
CLR.4: 5 residues within 4Å:- Chain A: G.955, R.958, Y.962
- Ligands: CLR.3, CLR.6
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:R.958, A:Y.962
CLR.5: 6 residues within 4Å:- Chain A: Q.856, L.859, L.860, A.863, F.959
- Ligands: CLR.6
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.859, A:A.863, A:F.959
CLR.6: 6 residues within 4Å:- Chain A: L.860, A.863, F.959, Y.962
- Ligands: CLR.4, CLR.5
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:A.863, A:F.959
CLR.7: 10 residues within 4Å:- Chain A: L.305, A.308, S.309, L.312, W.315, N.753, S.756, L.757, L.760
- Ligands: CLR.9
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.305, A:L.757, A:L.757, A:L.760
- Hydrogen bonds: A:N.753
CLR.8: 4 residues within 4Å:- Chain A: K.213, L.216, V.217, A.220
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:K.213, A:V.217, A:A.220, A:A.220
- Hydrogen bonds: A:K.213
CLR.9: 7 residues within 4Å:- Chain A: A.220, I.221, V.224, L.312, W.315, Y.316
- Ligands: CLR.7
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.221, A:L.312, A:W.315, A:Y.316, A:Y.316
CLR.10: 8 residues within 4Å:- Chain A: I.836, N.839, I.840, L.843, G.844, I.848, S.992
- Ligands: CLR.11
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.836, A:N.839, A:I.840, A:L.843, A:I.848
- Hydrogen bonds: A:R.832
CLR.11: 8 residues within 4Å:- Chain A: L.843, I.847, L.862, V.865, A.869, V.873, S.992
- Ligands: CLR.10
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.843, A:I.847, A:L.862, A:V.865, A:V.873
- Hydrogen bonds: A:S.992, A:S.992
CLR.12: 8 residues within 4Å:- Chain A: A.63, L.67, L.70, V.71, E.74, Y.117, I.121
- Ligands: CLR.13
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.70, A:V.71, A:Y.117, A:I.121
CLR.13: 6 residues within 4Å:- Chain A: A.63, L.67, L.70, T.202, T.209
- Ligands: CLR.12
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:A.63, A:L.67, A:L.70, A:T.202
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nosol, K. et al., Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1. Proc.Natl.Acad.Sci.USA (2020)
- Release Date
- 2020-10-14
- Peptides
- Multidrug resistance protein 1: A
MRK16 Fab-fragment light chain: B
MRK16 Fab-fragment heavy chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 2 x R1H: tariquidar(Non-covalent)
- 11 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nosol, K. et al., Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1. Proc.Natl.Acad.Sci.USA (2020)
- Release Date
- 2020-10-14
- Peptides
- Multidrug resistance protein 1: A
MRK16 Fab-fragment light chain: B
MRK16 Fab-fragment heavy chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.